483 Fougera Pharmaceuticals Oct 2013

483 Fougera Pharmaceuticals Oct 2013

$119 - Not in Stock

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued inspectional observations (via FDA 483) on 31 Oct 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Oct 2013
  • Location: Melville, United States
  • FEI: 2432435
Order